Skip to main content

Table 1 Positive rates of serum CEA, CA19-9 and CA72-4 levels

From: CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy

groups

Case

 

preoperative

   

postoperative

CEA(+)

CA19-9(+)

CA72-4(+)

 

CEA(+)

CA19-9(+)

CA72-4(+)

stage I and II GC (%)a

278

48(17.3)

27(9.7)

45(16.2)

 

37(13.3)

10(3.6)

23(8.3)

stage III (%)a

302

90(29.8)*

67(22.2)*

60(19.9)

 

74(24.5)*

42 (13.9)*

38(12.6)

  1. GC: Gastric Cancer; CEA(+): CEA > 5 ng/mL; CA19-9(+): CA19-9 > 35 U/mL; CA72-4(+): CA72-4 > 6.9 U/mL; aPearson chi-squared test or Fisher’s exact test; compared with the stage I and II GC group, *P < 0.05
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us